Brief: Oxigene qtrly loss per share $0.13
09/05/2016 13:00
May 9 (Reuters) - Oxigene Inc OXGN.O
* Qtrly loss per share $0.13
* Q1 earnings per share view $-0.19 -- Thomson Reuters
I/B/E/S
* Oxigene reports first quarter 2016 financial results
Source text for Eikon: ID:nGNXMRINFa
Further company coverage: OXGN.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas